{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:30:20Z","timestamp":1792182620544,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Ministry of Economy and Competitiveness | Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD11\/00277"],"award-info":[{"award-number":["CD11\/00277"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41423-019-0254-9","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T07:12:45Z","timestamp":1561533165000},"page":"954-965","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["BANK1 interacts with TRAF6 and MyD88 in innate immune signaling in B cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1256-5805","authenticated-orcid":false,"given":"Ina","family":"Georg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"D\u00edaz-Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7706-3243","authenticated-orcid":false,"given":"Angel L.","family":"Pey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Alarc\u00f3n-Riquelme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,26]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaut.2016.08.001","volume":"74","author":"M Teruel","year":"2016","unstructured":"Teruel, M. & Alarc\u00f3n-Riquelme, M. E. The genetic basis of systemic lupus erythematosus:what are the risk factors and what have we learned. J. Autoimmun. 74, 161\u2013175 (2016).","journal-title":"J. Autoimmun."},{"key":"254_CR2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.amjmed.2011.09.010","volume":"125","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals, M., Sanz, I., Bosch, X., Stone, J. H. & Khamashta, M. A. B-cell-depleting therapy in systemic lupus erythematosus. Am. J. Med. 125, 327\u2013336 (2012).","journal-title":"Am. J. Med."},{"key":"254_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1242\/dmm.016451","volume":"7","author":"SP Crampton","year":"2014","unstructured":"Crampton, S. P., Morawski, P. A. & Bolland, S. Linking susceptibility genes and pathogenesis mechanisms using mouse models of systemic lupus erythematosus. Dis. Model Mech. 7, 1033\u20131046 (2014).","journal-title":"Dis. Model Mech."},{"key":"254_CR4","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1177\/0961203310370350","volume":"19","author":"H-S Lee","year":"2010","unstructured":"Lee, H.-S. & Bae, S.-C. What can we learn from genetic studies of systemic lupus erythematosus? Implications of genetic heterogeneity among populations in SLE. Lupus 19, 1452\u20131459 (2010).","journal-title":"Lupus"},{"key":"254_CR5","doi-asserted-by":"crossref","first-page":"e1001311","DOI":"10.1371\/journal.pgen.1001311","volume":"7","author":"KE Taylor","year":"2011","unstructured":"Taylor, K. E. et al. Risk alleles for systemic lupus erythematosus in a large case-control collection and associations with clinical subphenotypes. PLoS Genet. 7, e1001311 (2011).","journal-title":"PLoS Genet."},{"key":"254_CR6","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000368585","volume":"128","author":"H Beckwith","year":"2014","unstructured":"Beckwith, H. & Lightstone, L. Rituximab in systemic lupus erythematosus and lupus nephritis. Nephron Clin. Pract. 128, 250\u2013254 (2014).","journal-title":"Nephron Clin. Pract."},{"key":"254_CR7","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1517\/14656566.2014.894976","volume":"15","author":"S-NC Liossis","year":"2014","unstructured":"Liossis, S.-N. C. & Melissaropoulos, K. Molecular abnormalities of the B cell in systemic lupus erythematosus are candidates for functional inhibition treatments. Expert Opin. Pharm. 15, 833\u2013840 (2014).","journal-title":"Expert Opin. Pharm."},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","volume":"10","author":"FB Vincent","year":"2014","unstructured":"Vincent, F. B., Morand, E. F., Schneider, P. & Mackay, F. The BAFF\/APRIL system in SLE pathogenesis. Nat. Rev. Rheumatol. 10, 365\u2013373 (2014).","journal-title":"Nat. Rev. Rheumatol."},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","volume":"220","author":"AM Krieg","year":"2007","unstructured":"Krieg, A. M. & Vollmer, J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev. 220, 251\u2013269 (2007).","journal-title":"Immunol. Rev."},{"key":"254_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrrheum.2009.278","volume":"6","author":"AN Theofilopoulos","year":"2010","unstructured":"Theofilopoulos, A. N. et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat. Rev. Rheumatol. 6, 146\u2013156 (2010).","journal-title":"Nat. Rev. Rheumatol."},{"key":"254_CR11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","volume":"23","author":"NM Green","year":"2011","unstructured":"Green, N. M. & Marshak-Rothstein, A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin. Immunol. 23, 106\u2013112 (2011).","journal-title":"Semin. Immunol."},{"key":"254_CR12","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","volume":"168","author":"V Hornung","year":"2002","unstructured":"Hornung, V. et al. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531\u20134537 (2002).","journal-title":"J. Immunol."},{"key":"254_CR13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy, E. J., Parker, A. E. & O\u2019Neill, L. A. J. Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9, 293\u2013307 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"254_CR14","doi-asserted-by":"crossref","first-page":"16276","DOI":"10.1073\/pnas.1209372109","volume":"109","author":"ER Walsh","year":"2012","unstructured":"Walsh, E. R. et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc. Natl Acad. Sci. USA 109, 16276\u201316281 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"e0153059","DOI":"10.1371\/journal.pone.0153059","volume":"11","author":"S Jain","year":"2016","unstructured":"Jain, S. et al. Interleukin 6 accelerates mortality by promoting the progression of the systemic lupus erythematosus-like disease of BXSB.Yaa mice. PLoS One 11, e0153059 (2016).","journal-title":"PLoS One"},{"key":"254_CR16","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.22197","volume":"54","author":"ED Papadimitraki","year":"2006","unstructured":"Papadimitraki, E. D. et al. Expansion of Toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis Rheumatol. 54, 3601\u20133611 (2006).","journal-title":"Arthritis Rheumatol."},{"key":"254_CR17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.2008.03646.x","volume":"152","author":"A Komatsuda","year":"2008","unstructured":"Komatsuda, A. et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin. Exp. Immunol. 152, 482\u2013487 (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"254_CR18","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-013-9887-0","volume":"33","author":"SK Chauhan","year":"2013","unstructured":"Chauhan, S. K., Singh, V. V., Rai, R., Rai, M. & Rai, G. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. J. Clin. Immunol. 33, 954\u2013964 (2013).","journal-title":"J. Clin. Immunol."},{"key":"254_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.05.001","volume":"61","author":"BD Lyn-Cook","year":"2014","unstructured":"Lyn-Cook, B. D. et al. Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol. Immunol. 61, 38\u201343 (2014).","journal-title":"Mol. Immunol."},{"key":"254_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20050338","volume":"202","author":"SR Christensen","year":"2005","unstructured":"Christensen, S. R. et al. Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J. Exp. Med. 202, 321\u2013331 (2005).","journal-title":"J. Exp. Med."},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0968-0004(02)02145-X","volume":"27","author":"S Janssens","year":"2002","unstructured":"Janssens, S. & Beyaert, R. A universal role for MyD88 in TLR\/IL-1R-mediated signaling. Trends Biochem. Sci. 27, 474\u2013482 (2002).","journal-title":"Trends Biochem. Sci."},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"23340","DOI":"10.1074\/jbc.M001950200","volume":"275","author":"L Li","year":"2000","unstructured":"Li, L., Cousart, S., Hu, J. & McCall, C. E. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275, 23340\u201323345 (2000).","journal-title":"J. Biol. Chem."},{"key":"254_CR23","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.082100399","volume":"99","author":"S Li","year":"2002","unstructured":"Li, S., Strelow, A., Fontana, E. J. & Wesche, H. IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl Acad. Sci. USA 99, 5567\u20135572 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/imr.12302","volume":"266","author":"MC Walsh","year":"2015","unstructured":"Walsh, M. C., Lee, J. & Choi, Y. Tumor necrosis factor receptor- associated factor 6 (TRAF6) regulation of development, function, and homeostasis of the immune system. Immunol. Rev. 266, 72\u201392 (2015).","journal-title":"Immunol. Rev."},{"key":"254_CR25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0092-8674(00)00126-4","volume":"103","author":"L Deng","year":"2000","unstructured":"Deng, L. et al. Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351\u2013361 (2000).","journal-title":"Cell"},{"key":"254_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/0014-5793(95)00931-X","volume":"371","author":"K Hofmann","year":"1995","unstructured":"Hofmann, K. & Tschopp, J. The death domain motif found in Fas (Apo-1) and TNF receptor is present in proteins involved in apoptosis and axonal guidance. FEBS Lett. 371, 321\u2013323 (1995).","journal-title":"FEBS Lett."},{"key":"254_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1994.1206","volume":"199","author":"D Hultmark","year":"1994","unstructured":"Hultmark, D. Macrophage differentiation marker MyD88 is a member of the Toll\/IL-1 receptor family. Biochem. Biophys. Res. Commun. 199, 144\u2013146 (1994).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"254_CR28","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nri3446","volume":"13","author":"LAJ O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A. J., Golenbock, D. & Bowie, A. G. The history of Toll-like receptors\u2014redefining innate immunity. Nat. Rev. Immunol. 13, 453\u2013460 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"254_CR29","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.immuni.2008.09.015","volume":"29","author":"I Isnardi","year":"2008","unstructured":"Isnardi, I. et al. IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity 29, 746\u2013757 (2008).","journal-title":"Immunity"},{"key":"254_CR30","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1172\/JCI40591","volume":"122","author":"MN Rivas","year":"2012","unstructured":"Rivas, M. N. et al. MyD88 is critically involved in immune tolerance breakdown at environmental interfaces of Foxp3-deficient mice. J. Clin. Investig. 122, 1933\u20131947 (2012).","journal-title":"J. Clin. Investig."},{"key":"254_CR31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4049\/jimmunol.1300683","volume":"192","author":"Z Hua","year":"2014","unstructured":"Hua, Z. et al. Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice. J. Immunol. 192, 875\u2013885 (2014).","journal-title":"J. Immunol."},{"key":"254_CR32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.gene.6364295","volume":"7","author":"CI Amos","year":"2006","unstructured":"Amos, C. I. et al. High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. Genes Immun. 7, 277\u2013286 (2006).","journal-title":"Genes Immun."},{"key":"254_CR33","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/art.34361","volume":"64","author":"B Namjou","year":"2012","unstructured":"Namjou, B. et al. Evaluation of TRAF6 in a large multiancestral lupus cohort. Arthritis Rheumatol. 64, 1960\u20131969 (2012).","journal-title":"Arthritis Rheumatol."},{"key":"254_CR34","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/383443a0","volume":"383","author":"Z Cao","year":"1996","unstructured":"Cao, Z., Xiong, J., Takeuchi, M., Kurama, T. & Goeddel, D. V. TRAF6 is a signal transducer for interleukin-1. Nature 383, 443\u2013446 (1996).","journal-title":"Nature"},{"key":"254_CR35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/jcs.115.4.679","volume":"115","author":"JY Chung","year":"2002","unstructured":"Chung, J. Y., Park, Y. C., Ye, H. & Wu, H. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J. Cell Sci. 115, 679\u2013688 (2002).","journal-title":"J. Cell Sci."},{"key":"254_CR36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature00888","volume":"418","author":"H Ye","year":"2002","unstructured":"Ye, H. et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418, 443\u2013447 (2002).","journal-title":"Nature"},{"key":"254_CR37","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.4049\/jimmunol.0902026","volume":"185","author":"MB Meads","year":"2010","unstructured":"Meads, M. B., Li, Z.-W. & Dalton, W. S. A novel TNF receptor-associated factor 6 binding domain mediates NF-kappa B signaling by the common cytokine receptor beta subunit. J. Immunol. 185, 1606\u20131615 (2010).","journal-title":"J. Immunol."},{"key":"254_CR38","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.278.5343.1612","volume":"278","author":"M Muzio","year":"1997","unstructured":"Muzio, M. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278, 1612\u20131615 (1997).","journal-title":"Science"},{"key":"254_CR39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/excr.1999.4733","volume":"254","author":"Ji Inoue","year":"2000","unstructured":"Inoue, J. et al. Tumor necrosis factor receptor-associated factor (TRAF) family: adapter proteins that mediate cytokine signaling. Exp. Cell Res. 254, 14\u201324 (2000).","journal-title":"Exp. Cell Res."},{"key":"254_CR40","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1074\/jbc.274.12.7724","volume":"274","author":"BG Darnay","year":"1999","unstructured":"Darnay, B. G., Ni, J., Moore, P. A. & Aggarwal, B. B. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif. J. Biol. Chem. 274, 7724\u20137731 (1999).","journal-title":"J. Biol. Chem."},{"key":"254_CR41","doi-asserted-by":"crossref","first-page":"24871","DOI":"10.1074\/jbc.M802749200","volume":"283","author":"B Lamothe","year":"2008","unstructured":"Lamothe, B. et al. The RING domain and first zinc finger of TRAF6 coordinate signaling by interleukin-1, lipopolysaccharide, and RANKL. J. Biol. Chem. 283, 24871\u201324880 (2008).","journal-title":"J. Biol. Chem."},{"key":"254_CR42","doi-asserted-by":"crossref","first-page":"e4736","DOI":"10.1371\/journal.pone.0004736","volume":"4","author":"T Kobayashi","year":"2009","unstructured":"Kobayashi, T. et al. TRAF6 is required for generation of the B-1a B cell compartment as well as T cell-dependent and -independent humoral immune responses. PLoS ONE 4, e4736 (2009).","journal-title":"PLoS One"},{"key":"254_CR43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/ng0408-484","volume":"40","author":"SV Kozyrev","year":"2008","unstructured":"Kozyrev, S. V. et al. Corrigendum: functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat. Genet. 40, 484 (2008).","journal-title":"Nat. Genet."},{"key":"254_CR44","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.24885","volume":"60","author":"P Dieud\u00e9","year":"2009","unstructured":"Dieud\u00e9, P. et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheumatol. 60, 3447\u20133454 (2009).","journal-title":"Arthritis Rheumatol."},{"key":"254_CR45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.24244","volume":"60","author":"G Orozco","year":"2009","unstructured":"Orozco, G. et al. Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheumatol. 60, 372\u2013379 (2009).","journal-title":"Arthritis Rheumatol."},{"key":"254_CR46","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/art.24748","volume":"60","author":"M Suarez-Gestal","year":"2009","unstructured":"Suarez-Gestal, M. et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis Rheumatol. 60, 2558\u20132564 (2009).","journal-title":"Arthritis Rheumatol."},{"key":"254_CR47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1073\/pnas.1118579109","volume":"109","author":"TD Troutman","year":"2012","unstructured":"Troutman, T. D. et al. Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine\/threonine kinases PI3K\/Akt. Proc. Natl Acad. Sci. USA 109, 273\u2013278 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/gene.2011.62","volume":"13","author":"SV Kozyrev","year":"2012","unstructured":"Kozyrev, S. V., Bernal-Quir\u00f3s, M., Alarc\u00f3n-Riquelme, M. E. & Castillejo-L\u00f3pez, C. The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization. Genes Immun. 13, 129\u2013138 (2012).","journal-title":"Genes Immun."},{"key":"254_CR49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/emboj\/21.1.83","volume":"21","author":"K Yokoyama","year":"2002","unstructured":"Yokoyama, K. et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. EMBO J. 21, 83\u201392 (2002).","journal-title":"EMBO J."},{"key":"254_CR50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2006.01.002","volume":"24","author":"Y Aiba","year":"2006","unstructured":"Aiba, Y. et al. BANK negatively regulates akt activation and subsequent B cell responses. Immunity 24, 259\u2013268 (2006).","journal-title":"Immunity"},{"key":"254_CR51","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clim.2016.10.018","volume":"173","author":"EM Dam","year":"2016","unstructured":"Dam, E. M. et al. The BANK1 SLE-risk variants are associated with alterations in peripheral B cell signaling and development in humans. Clin. Immunol. 173, 171\u2013180 (2016).","journal-title":"Clin. Immunol."},{"key":"254_CR52","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.4049\/jimmunol.1301203","volume":"191","author":"Y-Y Wu","year":"2013","unstructured":"Wu, Y.-Y., Kumar, R., Haque, M. S., Castillejo-Lopez, C. & Alarcon-Riquelme, M. E. BANK1 controls CpG-induced IL-6 secretion via a p38 and MNK1\/2\/eIF4E translation initiation pathway. J. Immunol. 191, 6110\u20136116 (2013).","journal-title":"J. Immunol."},{"key":"254_CR53","doi-asserted-by":"crossref","first-page":"e0156302","DOI":"10.1371\/journal.pone.0156302","volume":"11","author":"Y-Y Wu","year":"2016","unstructured":"Wu, Y.-Y., Kumar, R., Iida, R., Bagavant, H. & Alarc\u00f3n-Riquelme, M. E. BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation. PLoS One 11, e0156302 (2016).","journal-title":"PLoS One"},{"key":"254_CR54","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248\u2013249 (2010).","journal-title":"Nat. Methods"},{"key":"254_CR55","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308\u2013311 (2001).","journal-title":"Nucleic Acids Res."},{"key":"254_CR56","unstructured":"Jiang, S. H. et al. Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus. Nat Commun 10, 2201 (2019)."},{"key":"254_CR57","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni1118","volume":"5","author":"T Kawai","year":"2004","unstructured":"Kawai, T. et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat. Immunol. 5, 1061\u20131068 (2004).","journal-title":"Nat. Immunol."},{"key":"254_CR58","doi-asserted-by":"crossref","first-page":"e59842","DOI":"10.1371\/journal.pone.0059842","volume":"8","author":"M Bernal-Quir\u00f3s","year":"2013","unstructured":"Bernal-Quir\u00f3s, M., Wu, Y.-Y., Alarc\u00f3n-Riquelme, M. E. & Castillejo-L\u00f3pez, C. BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling. PLoS ONE 8, e59842 (2013).","journal-title":"PLoS One"},{"key":"254_CR59","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1126\/science.1160489","volume":"322","author":"H-CS Yen","year":"2008","unstructured":"Yen, H.-C. S., Xu, Q., Chou, D. M., Zhao, Z. & Elledge, S. J. Global protein stability profiling in mammalian cells. Science 322, 918\u2013923 (2008).","journal-title":"Science"},{"key":"254_CR60","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1074\/jbc.M116.761528","volume":"292","author":"S Halabi","year":"2017","unstructured":"Halabi, S., Sekine, E., Verstak, B., Gay, N. J. & Moncrieffe, M. C. Structure of the Toll\/Interleukin-1 receptor (TIR) domain of the B-cell adaptor that links phosphoinositide metabolism with the negative regulation of the Toll-like receptor (TLR) signalosome. J. Biol. Chem. 292, 652\u2013660 (2017).","journal-title":"J. Biol. Chem."},{"key":"254_CR61","doi-asserted-by":"publisher","unstructured":"Mart\u00ednez-Bueno, M. et al. Trans-ethnic mapping of BANK1 identifies two independent SLE-risk linkage groups enriched for co-transcriptional splicing marks. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19082331 (2018).","DOI":"10.3390\/ijms19082331"},{"key":"254_CR62","doi-asserted-by":"crossref","first-page":"35759","DOI":"10.1074\/jbc.M110.126904","volume":"285","author":"T Into","year":"2010","unstructured":"Into, T., Inomata, M., Niida, S., Murakami, Y. & Shibata, K. Regulation of MyD88 aggregation and the MyD88-dependent signaling pathway by sequestosome 1 and histone deacetylase 6. J. Biol. Chem. 285, 35759\u201335769 (2010).","journal-title":"J. Biol. Chem."},{"key":"254_CR63","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai, T. & Akira, S. TLR signaling. Cell Death Differ. 13, 816\u2013825 (2006).","journal-title":"Cell Death Differ."},{"key":"254_CR64","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1523\/JNEUROSCI.4474-04.2005","volume":"25","author":"KL Lim","year":"2005","unstructured":"Lim, K. L. et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002\u20132009 (2005).","journal-title":"J. Neurosci."}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0254-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41423-019-0254-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:04Z","timestamp":1684617724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-019-0254-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,26]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1038\/s41423-019-0254-9","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,26]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}